Literature DB >> 30638198

A Customizable Protocol for String Assembly gRNA Cloning (STAgR).

Christopher T Breunig1, Andrea M Neuner1, Jessica Giehrl-Schwab2, Wolfgang Wurst2, Magdalena Götz3, Stefan H Stricker4.   

Abstract

The bacterial CRISPR/Cas9 system has substantially increased methodological options for life scientists. Due to its utilization, genetic and genomic engineering became applicable to a large range of systems. Moreover, many transcriptional and epigenomic engineering approaches are now generally feasible for the first time. One reason for the broad applicability of CRISPR lies in its bipartite nature. Small gRNAs determine the genomic targets of the complex, variants of the protein Cas9, and the local molecular consequences. However, many CRISPR approaches depend on the simultaneous delivery of multiple gRNAs into individual cells. Here, we present a customizable protocol for string assembly gRNA cloning (STAgR), a method that allows the simple, fast and efficient generation of multiplexed gRNA expression vectors in a single cloning step. STAgR is cost-effective, since (in this protocol) the individual targeting sequences are introduced by short overhang primers while the long DNA templates of the gRNA expression cassettes can be re-used multiple times. Moreover, STAgR allows single step incorporation of a large number of gRNAs, as well as combinations of different gRNA variants, vectors and promoters.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30638198     DOI: 10.3791/58556

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  1 in total

1.  CRISPR-Mediated Induction of Neuron-Enriched Mitochondrial Proteins Boosts Direct Glia-to-Neuron Conversion.

Authors:  Gianluca L Russo; Giovanna Sonsalla; Poornemaa Natarajan; Christopher T Breunig; Giorgia Bulli; Juliane Merl-Pham; Sabine Schmitt; Jessica Giehrl-Schwab; Florian Giesert; Martin Jastroch; Hans Zischka; Wolfgang Wurst; Stefan H Stricker; Stefanie M Hauck; Giacomo Masserdotti; Magdalena Götz
Journal:  Cell Stem Cell       Date:  2020-11-16       Impact factor: 24.633

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.